Abstract

A Case of Female Osteoporosis: A 50-Year-Old Postmenopausal Woman with Zoledronic Acid-Induced Uveitis

Sophy S*

Zoledronic Acid (ZA) is a third-generation bisphosphonate, most commonly used for the treatment of several conditions like postmenopausal osteoporosis, metastatic disease to the bone, hypercalcemia, Paget’s disease and multiple myeloma. In this study, we describe a 50-year-old lady who developed eye pain and redness after zoledronic acid infusion, given for controlling hypercalcemia, when she presented with hypercalcemia induced pancreatitis.

Published Date: 2024-09-16; Received Date: 2021-01-07